D-1391-2020 Class III Terminated

Recalled by Fresenius Kabi USA, LLC — Lake Zurich, IL

FDA drug recall D-1391-2020 was initiated by Fresenius Kabi USA, LLC on Jul 13, 2020 and is designated Class III. Reason for recall: Labeling Error: Label Error on Declared Strength: Carton label and product insert incorrectly states the quantity of the excipient edetate disodium (EDTA) as 5.4 mg / vial, rather than the actual… The recall status is terminated (terminated Aug 19, 2022). Affected quantity: 63,067 vials.

Recall details

Product Type
Drugs
Report Date
Jul 22, 2020
Initiation Date
Jul 13, 2020
Termination Date
Aug 19, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
63,067 vials

Product description

Fosaprepitant for Injection, 150 mg / vial in a 10 mL Single-Dose vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047; NDC 63323-972-10

Reason for recall

Labeling Error: Label Error on Declared Strength: Carton label and product insert incorrectly states the quantity of the excipient edetate disodium (EDTA) as 5.4 mg / vial, rather than the actual amount of 18.8 mg / vial.

Distribution pattern

Nationwide within the United States

Code information

Lot #: 6122760, 6122761, exp 08/2021; 6122762, exp 09/2021; 6123883, exp 03/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1391-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1391-2020. Report a data issue: hello@regdatalab.com.